References
- Wong MC, Tam WW, Wang HH, Cheung CS, Tong EL, Cheung NT, Leeder SR, Griffiths SM, et al. Duration of initial antihypertensive prescription and medication adherence: a cohort study among 203,259 newly diagnosed hypertensive patients. Int J Cardiol. 2015;182:503–08.
- Wang HH, Wang JJ, Wong SY, Wong MC, Li FJ, Wang PX, et al. Epidemiology of multimorbidity in China and implications for the healthcare system: cross-sectional survey among 162,464 community household residents in southern China. BMC Med. 2014;12(1):188. doi:https://doi.org/10.1186/s12916-014-0188-0.
- Lawes CM, Vander Hoorn S, Rodgers A.Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–18. doi:https://doi.org/10.1016/S0140-6736(08)60655-8.
- Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, Chen Y, Bian Z, Chen J, Meng J, et al. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern Med. 2016;176(4):524–32. doi:https://doi.org/10.1001/jamainternmed.2016.0190.
- Li W, Gu H, Teo KK, Bo J, Wang Y, Yang J, et al. Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China. J Hypertens. 2016;34(1):39–46. doi:https://doi.org/10.1097/HJH.0000000000000745.
- Wang J, Zhang L, Wang F, Liu L, Wang H.Prevalence, awareness, treatment, and control of hypertension in China: results from a national survey. Am J Hypertens. 2014;27(11):1355–61. doi:https://doi.org/10.1093/ajh/hpu053.
- Law MR, Morris JK, Wald NJ.Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Bmj. 2009;338(may19 1):b1665.doi:https://doi.org/10.1136/bmj.b1665.
- Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD.Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011;29(2):179–88. doi:https://doi.org/10.1097/HJH.0b013e328340d76f.
- National Center for Cardiovascular Diseases NCoHMiPHC. National clinical practice guidelines on the management of hypertension in primary health care in China (2020). Chin J Front Med Sci. 2021;13(4):26–37.
- Liu S, Yuan H, Jiang C, Xu J, Qiu X, Luo J.The blood pressure control and arteriosclerotic cardiovascular risk among Chinese community hypertensive patients. Sci Rep. 2021;11(1):19066. doi:https://doi.org/10.1038/s41598-021-98745-8.
- Fan LM, Wang F, Zhao M, Cui WL, Cai L.Socioeconomic differentials in trends in the prevalence of hypertension and pre-hypertension and hypertension awareness, treatment, and control in rural Southwestern China. BMC Cardiovasc Disord. 2021;21(1):259. doi:https://doi.org/10.1186/s12872-021-02062-x.
- Liu L, Quang ND, Banu R, Kumar H, Tham YC, Cheng CY, Wong TY, Sabanayagam C, et al. Hypertension, blood pressure control and diabetic retinopathy in a large population-based study. PLoS One. 2020;15(3):e0229665. doi:https://doi.org/10.1371/journal.pone.0229665.
- Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al. Status of Hypertension in China: results From the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–56. doi:https://doi.org/10.1161/CIRCULATIONAHA.117.032380.
- Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58. doi:https://doi.org/10.1016/S0140-6736(17)32478-9.
- Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014;37:253–390.
- Kim SH, Shin DW, Kim S, Han K, Park SH, Kim YH, Jeon S-A, Kwon Y-C, et al. Prescribing Patterns of Antihypertensives for Treatment-Naïve Patients in South Korea: from Korean NHISS Claim Data. Int J Hypertens. 2019;2019:4735876.
- Liu PH, Wang JD.Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan. BMC Health Serv Res. 2008;8(1):133.doi:https://doi.org/10.1186/1472-6963-8-133.
- Feng XL, Pang M, Beard J.Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41. doi:https://doi.org/10.2471/BLT.13.124495.
- Jarari N, Rao N, Peela JR, Ellafi KA, Shakila S, Said AR, Nelapalli NK, Min Y, Tun KD, Jamallulail SI, et al. A review on prescribing patterns of antihypertensive drugs. Clin Hypertens. 2015;22(1):7. doi:https://doi.org/10.1186/s40885-016-0042-0.
- Ishida T, Oh A, Hiroi S, Shimasaki Y, Tsuchihashi T.Current prescription status of antihypertensive drugs in Japanese patients with hypertension: analysis by type of comorbidities. Clin Exp Hypertens. 2019;41(3):203–10. doi:https://doi.org/10.1080/10641963.2018.1465074.
- Xu H, He Y, Xu L, Yan X, Dai H.Trends and patterns of five antihypertensive drug classes between 2007 and 2012 in China using hospital prescription data. Int J Clin Pharmacol Ther. 2015;53(6):430–37.
- Kohro T, Yamazaki T, Sato H, Ohe K, Nagai R.The impact of a change in hypertension management guidelines on diuretic use in Japan: trends in antihypertensive drug prescriptions from 2005 to 2011. Hypertens Res. 2013;36(6):559–63. doi:https://doi.org/10.1038/hr.2012.216.
- Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iwasaki K, Ohishi M.Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data. Hypertens Res. 2016;39(12):907–12. doi:https://doi.org/10.1038/hr.2016.96.
- Alkaabi MS, Rabbani SA, Rao PGM, Ali SR.Prescription Pattern of Antihypertensive Drugs: an Experience from a Secondary Care Hospital in the United Arab Emirates. J Res Pharm Pract. 2019;8(2):92–100. doi:https://doi.org/10.4103/jrpp.JRPP_18_85.
- Ah Y-M, Lee J-Y, Choi Y-J, Kim B, Choi KH, Kong J, et al. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: effects of Initial Therapeutic Classes. J Korean Med Sci. 2015;30(12):1800–06. doi:https://doi.org/10.3346/jkms.2015.30.12.1800.
- Ishida T, Oh A, Hiroi S, Shimasaki Y, Nishigaki N, Tsuchihashi T.Treatment patterns and adherence to antihypertensive combination therapies in Japan using a claims database. Hypertens Res. 2019;42(2):249–56. doi:https://doi.org/10.1038/s41440-018-0127-0.
- Varakantham V, Kurakula Sailoo AK, Bharatraj DK.Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: a Cross-sectional Retrospective Study. Hosp Pharm. 2018;53(2):107–12. doi:https://doi.org/10.1177/0018578717738080.
- Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, et al. Patterns and Correlates of Baseline Thiazide-Type Diuretic Prescription in the Systolic Blood Pressure Intervention Trial. Hypertension. 2016;67(3):550–55. doi:https://doi.org/10.1161/HYPERTENSIONAHA.115.06851.
- Qvarnström M, Kahan T, Kieler H, Brandt L, Hasselström J, Boström KB, Manhem K, Hjerpe P, Wettermark B, et al. Persistence to antihypertensive drug classes: a cohort study using the Swedish Primary Care Cardiovascular Database (SPCCD). Med (Baltimore). 2016;95(40):e4908. doi:https://doi.org/10.1097/MD.0000000000004908.
- Blix HS, Landmark K, Selmer R, Reikvam A.Patterns in the prescription of antihypertensive drugs in Norway, 1975–2010. Tidsskr Nor Laegeforen. 2012;132(10):1224–28. doi:https://doi.org/10.4045/tidsskr.11.0984.
- Sica DA, Carter B, Cushman W, Hamm L.Thiazide and loop diuretics. J Clin Hypertens (Greenwich). 2011;13(9):639–43. doi:https://doi.org/10.1111/j.1751-7176.2011.00512.x.
- Ohishi M, Yoshida T, Oh A, Hiroi S, Takeshima T, Otsuka Y, et al. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study. Hypertens Res. 2019;42(7):1057–67. doi:https://doi.org/10.1038/s41440-019-0238-2.
- Chinese Society of Cardiology CMDAHC. Chinese guidelines for the management of hypertension. Chin J Cardiovasc Med. 2019;24(1):24–56. 2018.
- Kaiser EA, Lotze U, Schäfer HH.Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging. 2014;9:459–75. doi:https://doi.org/10.2147/CIA.S40154.
- Bangalore S, Parkar S, Grossman E, Messerli FH.A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus. Am J Cardiol. 2007;100(8):1254–62. doi:https://doi.org/10.1016/j.amjcard.2007.05.057.